Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2006 059 607.3 |
96 | EP file number | EAKZ | 17 15 4940.5 |
97 | EP publication number | EPN | 3184631 |
54 | Designation/title | TI | ZELLENPOPULATIONEN MIT IMMUNREGULATORISCHER AKTIVITÄT, ISOLIERVERFAHREN UND VERWENDUNGEN |
51 | IPC main class | ICM (ICMV) | C12N 5/0783 (2010.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C12N 5/0775 (2010.01), A61K 35/12 (2015.01), A61P 37/08 (2006.01) |
22 | DE application date | DAT | Sep 22, 2006 |
96 | EP application date | EAT | Sep 22, 2006 |
43 | Date of first publication | OT | Jun 28, 2017 |
| Date of publication of grant | PET | Aug 12, 2020 |
71/73 | Applicant/owner | INH | Consejo Superior de Investigaciónes Científicas, Madrid, ES; Takeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP |
72 | Inventor | IN | BÜSCHER, Dirk, E-28760 Tres Cantos, Madrid, ES; GONZÁLEZ DE LA PEÑA, Manuel Ángel, E-28760 Tres Cantos, Madrid, ES; DELGADO MORA, Mario, 18106 Armilla- Granada, ES |
74 | Representative | VTR | Maiwald GmbH, 80335 München, DE |
| Address for service | | Maiwald GmbH, 80065 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| EP 05077186 Sep 23, 2005
|
| Due date | FT FG | Sep 30, 2025 Annual fee for the 20th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003184631A1 Searchable text:
EP000003184631A1 Original document:
EP000003184631B1 Searchable text:
EP000003184631B1 |
43 | Date of first publication | EVT | Jun 28, 2017 |
| Date of the first transfer into DPMAregister | EREGT | Jun 30, 2017 |
| Date of the (most recent) update in DPMAregister | REGT | Aug 28, 2024 (Show all update days)(Hide all update days)- Aug 28, 2024
- May 17, 2024; Sep 6, 2023; Oct 24, 2022; Oct 8, 2022; Aug 27, 2022; Aug 13, 2021; Jul 29, 2021; Jun 24, 2021; Sep 21, 2020; Aug 27, 2020; Jul 23, 2020; Aug 22, 2019; May 16, 2019
- Historical data not available for this/these date(s)
- Jun 30, 2017
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 6)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Oct 7, 2022 |
| Issue number | HN | 46 |
| Year | PJ | 2022 |
| Publication date | VT | Nov 17, 2022 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Consejo Superior de Investigaciónes Científicas, Madrid, ES; Takeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP |
71/73 | Previous applicant/owner | INHF | Consejo Superior de Investigaciónes Científicas, Madrid, ES, TiGenix, S.A.U., Tres Cantos, Madrid, ES |
| Date of update of the procedure | REGT | Oct 24, 2022 |